The Internal Revenue Service (IRS) is at a crossroads yet again, grappling with an identity crisis that spans from leadership instability to a muddled regulatory framework. Without a permanent commissioner, the agency is trapped in a whirlwind of political disputes—a toxic cocktail of bureaucracy that inhibits progress. The, often disregarded, voice of the National Association
0 Comments
The recent approval of Merck’s vaccine Enflonsia by the Food and Drug Administration (FDA) marks a significant milestone in pediatric healthcare. Respiratory Syncytial Virus (RSV) is notorious for posing serious risks to infants, especially during their vulnerable first year. The reality is sobering: RSV-related complications lead to thousands of hospitalizations and a shocking number of
0 Comments